GXXYGALEXXY HLDGS INC.

About GALEXXY HLDGS INC. (GXXY)

GALEXXY HLDGS INC. (GXXY) is a Drug Manufacturers - Specialty & Generic company headquartered in Dana Point, CA, United States whose shares trade over-the-counter on the Pink tier.

Galexxy Holdings, Inc. (The Company or GXXY) (OTC: GXXY) is a company in the health and wellness sector, driven by a mission to introduce distinctive and impactful health and wellness products to markets worldwide. Galexxy is strategically focused on being vertically integrated through acquiring wellness-oriented businesses. Galexxy aims to enhance marketing strategies, broaden distribution channels, and bolster revenues, all with the overarching goal of delivering value to shareholders and expanding consumer access on a global scale. The Company's diverse portfolio includes ownership in entities such as Wellbeing Farms LLC (WBF), a producer and distributor of functional mushroom health supplements, and Adaptin LLC, a direct to consumer brand, specializing in functional mushroom and adaptogen products. The company was formerly known as AgTech Global International, Inc. and changed its name to Galexxy Holdings, Inc. in March 2022. Galexxy Holdings, Inc. was incorporated in 2000 and is based in Newport Beach, California.

Products and services

Functional mushroom products, through our Adaptin and Wellbeing Farms brands, remains Galexxy Holdings’ core product range. We offer a unique range of Functional Mushrooms, combined with targeted adaptogens, to create specific blends that assist with – Energy, Focus, Wellbeing, Calm, Sleep, and Immunity. Our product range includes Gummies, Glycerite Tinctures and Capsules made with the highest quality ingredients that include 100-day triple extracted US grown mushrooms.

GXXY key facts

Ticker symbol

GXXY

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Dana Point, CA, United States

Country of incorporation

US

Year of incorporation

2000

Employees

3

Estimated market cap

$2.16M (as of Apr 11, 2025)

Shares outstanding

284,311,880

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

12/31

Latest filing

Quarterly Report (Sep 30, 2024)

GALEXXY HLDGS INC. leadership

• Iain G Saul — Officer
• Michael Biagi — CEO
• Rodney Sperry — Interim CFO
• Rachel Fyffe — VP, Corp. Comm.

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with G